3.27MMarket Cap-61P/E (TTM)
0.3772High0.3400Low97.33KVolume0.3610Open0.3450Pre Close34.28KTurnover1.09%Turnover RatioLossP/E (Static)9.61MShares2.505052wk High0.41P/B3.04MFloat Cap0.282152wk Low--Dividend TTM8.94MShs Float59.5990Historical High--Div YieldTTM10.78%Amplitude0.2821Historical Low0.3520Avg Price1Lot Size
Petros Pharmaceuticals Stock Forum
Accesswire· 1 min ago
Utilization of the Company's proprietary Web App showed improved self-selection utilizing an embedded validated diagnostic questionnaire compared to a live interview furthering the Company's efforts to potentially create ...
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), commonly referred to as "Petros" or "the Company," has recently announced the results of a pivotal study aimed at enabling over-the-counter (OTC) access to STENDRA® (avanafil). This development represents a step forward in the Compa...
Petros Pharmaceuticals' Stendra(R) (Avanafil) Pivotal Consumer Self-Selection Study for Over--Counter Access Demonstrates Statistical Significance
No comment yet